| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| LILRB2 |
|
leukocyte immunoglobulin like receptor B2
|
|
1.3E-14 |
0.623 |
0.615 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| IBD5 |
|
inflammatory bowel disease 5
|
|
|
0.705 |
0.538 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| BMS1P20 |
|
BMS1 pseudogene 20
|
|
|
0.682 |
0.577 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| TRIM39-RPP21 |
|
TRIM39-RPP21 readthrough
|
|
0.74 |
0.821 |
0.269 |